(Q35103647)

6 August 2017

1 reference

title

Vaccine for AIDS and Ebola virus infection (English)

1 reference

6 August 2017

0 references

Orthoebolavirus zairense

0 references

1

Gary J Nabel

1 reference

6 August 2017

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

92

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

213-217

1 reference

Emerging diseases. On the trail of Ebola and Marburg viruses

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Ebola haemorrhagic fever--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

1 reference

7 January 2021

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Extensive variation of human immunodeficiency virus type-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900354-4

7 January 2021

10.1016/S0168-1702(02)00354-4

Identifiers

DOI

1 reference

6 August 2017

1 reference